singapore without covid vaccine drug world would still lockdown  overwhelmed hospital empty street many u stuck home instead many country resumed social economic activity varying degree breathe little easier knowing covid mild disease vast majority vaccinated know new drug vaccine advance protect human health covid pandemic ha shown public expects undergo stringent clinical trial reassure u safety efficacy necessarily mean brave people step test behalf rest u volunteer worldwide participated pfizerbiontech moderna vaccine study beginning first half result published peerreviewed scientific journal regulatory agency authorised emergency use company also conducted similar trial child human volunteer needed clinical trial phase gather specific information drug vaccine  processed human body whether give rise side effect effect target disease singapore many people responded recruitment call early phase clinical trial novel selfamplifying mrna covid vaccine conducted singapore general hospital national university hospital national centre infectious diseases vaccine wa codeveloped dukenus medical school united states biotechnology company arcturus therapeutics clockwise top left singapore general hospital photo wee teck hiantoday national centre infectious diseases photo afproslan rahman national university hospital file photo dukenus medical school photo dukenus medical school phase study alone volunteer aged stepped forward join help fight pandemic early august really stood u involved wa enthusiastic response wa especially heartening see volunteer pioneer generation stepping forward continue contributing singapore clinical trials excellent safety records safe sign volunteer untested vaccine first volunteer guinea pig human testing ever done without extensive preclinical testing animal model animal testing replace human trial immune response dont work exact way second clinical trial many country strictly governed singapore trial proceed approval two independent body  health sciences authority regulatory authority healthcare institutional ethic board consists doctor scientist must include lay people religious leader lawyer third participant equipped make informed personal choice informed aspect trial including treatment option potential side effect benefit treatment encouraged ask question raise concern participants withdraw trial time reason without penalty fourth requisite monitoring assessment adverse effect response treatment clinical trial rigorous cautious detailed many clinical trial also data safety monitoring board expert independent product developed review safety viability trial progress give assurance continue finally procedure safeguarded law mean trial halted organiser penalised conducted accordance altruism motivation factors volunteering every year thousand volunteer singapore many across world participate clinical trial motivational factor vary altruism usually clear motivator observed dukenusarcturus trial wanting contribute solution global pandemic major disease its almost main factor needed phase trial healthy volunteer recruited test sample dos new medicine first time human derivation personal benefit another major motivational force patients participate clinical trial front row seat evolving science covid first volunteer trial pfizerbiontech moderna covid vaccine globally first protected disease ahead rest world look vaccine trial conducted related commentary parent sibling refuse covid vaccination besides vaccine singapore ha participated clinical trial new covid treatment infected patient signed access promising therapy remdesivir first monoclonal antibody cocktail could potentially help recover rapidly benefit conducting local clinical trial particularly new drug patients make informed decision type care option available condition yet treated effectively consider proactively seeking clinical trial opportunity consider new type care could improve medical care gold standard healthcare hospitals motivated conduct clinical trial despite massive work resource required allows doctor access cuttingedge therapy also disposal current evidencebased care trial treatment compared patient singapore ultimately benefit gold standard care related singapores race vaccine second wave covid hit commentary variants versus vaccine becoming new covid race commentary myth covid vaccine womens fertility hospital biomedical research infrastructure worldclass well placed conduct early latephase clinical trial thereby ensuring safety effectiveness new drug vaccine among singapores diverse population indeed every medical institution singapore actively engage clinical trial ensure singapore population ha access highest quality healthcare routinely next time see doctor hospital ask active clinical trial consider joining could part special group people helping make sure new drug vaccine rolled indeed safe effective dr jenny low associate professor emerging infectious diseases programme dukenus medical school senior consultant department infectious diseases singapore general hospital dr louis chai associate professor nus yong loo lin school medicine senior consultant division infectious diseases department medicine national university hospital dr barnaby young head singapore infectious disease clinical research network national centre infectious diseases dr ooi eng eong professor emerging infectious diseases programme dukenus medical school still deciding booster shot listen two infectious disease specialist discus covid vaccine cnas heart matter